Skip to main content
Year archive

EyeGene,Inc — 2019 filings

All 26 regulatory filings released by EyeGene,Inc (185490) in 2019, sourced directly from the official regulator.

26 Filings
2019 Period
2019 filings (26)
Filing Released Lang
투자판단관련주요경영사항(대상포진 예방백신 ‘EG-HZ’ 호주 임상1상 시험 계획 승인)
Regulatory Filings
2019-12-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-12 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 이를 포함하는 면역보조제 조성물)
Regulatory Filings
2019-11-06 Korean
전환가액의조정(제1회차)
Capital/Financing Update
2019-09-16 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-23 Korean
기타경영사항(자율공시)(2019년 연결대상 적용에 따른 반기보고서 제출 기한 연장)
Regulatory Filings
2019-08-16 Korean
전환가액의조정(제1회차)
Capital/Financing Update
2019-06-14 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
기업설명회(IR)개최
Regulatory Filings
2019-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-04-05 Korean
사업보고서 (2018.12)
Annual Report FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-22 Korean
감사보고서제출
Report Publication Announcement
2019-03-14 Korean
전환가액의조정(제1회차)
Capital/Financing Update
2019-03-14 Korean
주주총회소집공고
AGM Information
2019-03-07 Korean
주주총회집중일개최사유신고
AGM Information
2019-03-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-03-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-03-06 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2019-03-05 Korean
주주총회소집결의
AGM Information
2019-03-05 Korean
투자판단관련주요경영사항(심근허혈 및 재관류 손상 치료제 ‘이지-마이오신 (EG-Myocin)’ 임상2상 시험 계획 승인)
Regulatory Filings
2019-02-19 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2018
2019-02-13 Korean
신규시설투자등
Capital/Financing Update
2019-02-13 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2019-01-07 Korean